Cyclacel Pharmaceuticals Current Ratio 2011-2026 | CYCC

Current Ratio Jährlich Cyclacel Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997
6.09	0.653	1.07	3.68	8	14.3	5.79	4.45	6.32	3.73	4.27	3.87	4.69	2.02	3.98	4.81	-	-	-	-	-	-	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
14.3	0.653	4.86

Current Ratio Vierteljährlich Cyclacel Pharmaceuticals

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9.41	7.68	5.72	5.56	0.65	0.85	1.14	0.74	1.07	1.52	2.41	2.97	3.67	6.96	6.88	6.37	8	12.4	14.9	13.8	10.4	10.4	10.4	10.4	4.24	4.24	4.24	4.24	4.36	4.36	4.36	4.36	6.14	6.14	6.14	6.14	3.65	3.65	3.65	3.65	4.18	4.18	4.18	4.18	3.82	3.82	3.82	3.82	4.74	4.74	4.74	4.74	2.07	2.07	2.07	2.07	4	4	4	4

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert	Mindestwert	Durchschnitt
14.9	0.65	5.05

Current Ratio anderer Aktien in der Pharmaeinzelhändler

Name	Current Ratio	Preis	% 24h	Marktkapitalisierung	Land
FSD Pharma HUGE	1.84	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Compugen Ltd. CGEN	7.46	$ 2.02	-0.98 %	$ 189 M	Israel
Happiness Biotech Group Limited HAPP	5.42	-	1.35 %	$ 17.8 M	China
Coherus BioSciences CHRS	1.31	$ 1.42	-	$ 166 M	USA
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	3.86	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	7.32	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	0.65	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	7.56	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	1.43	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	0.796	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	3.2	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	11.2	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	2.68	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	1.69	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	6.6	$ 51.48	-0.23 %	$ 4.63 B	Schweiz
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	8.41	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	1.88	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	2.69	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	10.4	$ 29.6	3.64 %	$ 1.97 B	USA
Generation Bio Co. GBIO	1.59	-	-	$ 344 M	USA
IMV IMV	0.826	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	6.17	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	6.09	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	2.53	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	5.9	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	14.4	$ 14.57	-0.21 %	$ 209 M	USA
Advaxis ADXS	3.37	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	1.22	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	2.76	$ 2.91	-5.52 %	$ 4.79 M	Israel
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	2.84	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	5.43	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	1.78	$ 22.79	5.8 %	$ 2.9 B	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA